EP Biocomposites shareholders and shareholding pattern
BSE: 543595Other UtilitiesSmall Cap
EP BIOCOMPOSITES LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2022
Last close ₹90.00up ₹3.00 (3.45%)
Share price at the BSE close on 27 Oct 2026. Previous close ₹87.00.
27 Oct: open ₹90.00, high ₹90.00, low ₹90.00
52-week range of traded prices to 27 Oct 2026
₹75.50Low, 30 Mar 2026₹139.00High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15 Cr4,283rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 10.38
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.26
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 500
EP Biocomposites' shareholding pattern for Sep 2026, filed on 20 Oct 2026, with every filing from Sep 2022: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns EP Biocomposites, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters70.08%
- Foreign institutionsNone
- Individuals and others29.92%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Individuals and others
| Per cent | Sep 2022 | Mar 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.31% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | |
| Indian promoters | 69.31% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% | 70.08% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 30.69% | 29.92% | 29.92% | 29.92% | 29.92% | 29.92% | 29.92% | 29.92% | 29.92% | 29.92% | 29.92% | 29.92% | 29.92% |
| Shares in issue | 16,81,500 | 16,81,500 | 16,81,500 | 16,81,500 | 16,81,500 | 16,81,500 | 16,81,500 | 16,81,500 | 16,81,500 | 16,81,500 | 16,81,500 | 16,81,500 | 16,81,500 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 11,77,500 | 11,77,500 | 3,45,000 | 3,45,000 | 3,45,000 | 3,45,000 | 3,45,000 | 3,45,000 | 3,45,000 | – | – | – | – |
| Promoters' shares locked in | 11,65,416 | 11,65,416 | 3,45,000 | 3,45,000 | 3,45,000 | 3,45,000 | 3,45,000 | 3,45,000 | 3,45,000 | – | – | – | – |
A dash is a line the filing did not state.
EP Biocomposites promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is LEENA RAJKUMAR KAMAT, 64.93%.
| Holder | ||
|---|---|---|
| LEENA RAJKUMAR KAMATIndividuals and Hindu undivided families | 64.93% | 10,91,848 |
| RAJKUMAR GAJANAN KAMATIndividuals and Hindu undivided families | 3.99% | 67,152 |
| NIMISHA RAJKUMAR KAMATIndividuals and Hindu undivided families | 0.84% | 14,208 |
| ASHMA RAJKUMAR KAMATIndividuals and Hindu undivided families | 0.31% | 5,208 |
No promoter shares are reported as pledged.
Largest public holders of EP Biocomposites, filing by filing
Per cent, on the same shares as the split above.
| Holder | Sep 2022 | Mar 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KAVITA KUMAR SANTOSHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | 1.72% | 2.08% | 2.26% | 2.32% |
| SAMBHAV DAWARResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | 1.04% | 1.04% | 1.61% | 1.61% | 1.61% | 1.61% |
| RAJIV MEHTAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | 1.31% | 1.31% | 1.31% | 1.31% |
| NAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUNDForeign portfolio investors, category I | 1.19% | 2.20% | 2.20% | 2.20% | – | – | – | – | – | – | – | – | – |
| TALIB ZAFARResident individuals, up to ₹2 lakh at face value | 1.25% | 1.07% | 1.07% | – | – | – | – | – | – | – | – | – | – |
| XTENDED BUSINESS REPORTINGCompanies | – | 1.55% | – | – | – | – | – | – | – | – | – | – | – |
| MAYURI SHRIPAL VORAResident individuals, up to ₹2 lakh at face value | – | 1.01% | – | – | – | – | – | – | – | – | – | – | – |
| SANJAY POPATLAL JAINResident individuals, over ₹2 lakh at face value | 2.97% | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: KAVITA KUMAR SANTOSH 2.32%, +0.06 pts